Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

Our art critic goes room-by-room through New York’s Gilded Age house museum, reopening after nearly five years. Don’t miss the new upstairs galleries. By Holland Cotter The darkly comic ...

This is an official Pytorch Implementation of "CXR-CLIP: Toward Large Scale Chest X-ray Language-Image Pre-training" [arxiv] ...